Nate Silver blasts 'disaster' FDA decision to halt Johnson & Johnson-entstof

Die FDA het die pouse aangekondig ná ses individuele gevalle van bloedklonte by vroue tussen die ouderdom van 18 en 48. Byna 7 million one-dose shots have been administered since the vaccine was approved for emergency use in late February.

“6 cases out of 7 miljoen mense. What a disaster,” Silver reacted on Twitter. “This is going to get people killed. And it’s going to create more vaccine hesitancy. These people don’t understand cost-benefit analysis. They keep making mistakes by orders of magnitude.

JOHNSON & JOHNSON VACCINE PAUSE OUTRAGES MEDIA ACROSS THE SPECTRUM: ‘THIS IS A MORONIC STEP

The political polling guru told another Twitter user the FDA had “misluk” sy “high-stakes testof messaging, since those skeptical of taking the vaccine may also write off the Pfizer and Moderna vaccines following the announcement. Silver also cited data showing public confidence in the AstraZeneca vaccine has plummeted in Europe following that vaccine’s pause.

Why did the FDA recommend the pause anyway? Because of a combination of institutional culture, cognitive biases, and bureaucratic imperatives incentives, they greatly overweight the importance of rare adverse effects relative to people dying from COVID,” Silver argued. “But unless they know about that institutional culture, it’s understandable that regular folks may think ‘hmm, maybe there’s more going on’. Especially when public health officials have eroded trust by telling a lot of ‘noble liesto people, bv. in the early days re: masks.

FDA REMENDS PAUSE OF JOHNSON & JOHNSON COVID-19 VACCINE AFTER BLOOD CLOT CASES

Silver then compared the FDA’s logic to a scenario in which California Gov. Gavin Newsom closed all beachesout of an abundance of cautionin order to investigate rare shark attacks, skryfwerk “that’s not likely to get more people to go out to the beach, even once beaches reopen.

I think it’s important though that there *hadn’t* been a particular public/media panic about blood clots and the J&J vaccine, darem nog nie,” Silver tweeted. “So the FDA is sort of creating a Streisand Effect and giving these concerns more salience.

Silver also acknowledged that while hecould be wrong,” he stressed that the pandemic has become apolitical/media focal pointand wondered if the FDA consults “kundiges” who can address broader concerns about such a decision.

In 'n verklaring, the FDA noted that the blood clotsappear to be extremely rareand added that the Centers for Disease Control and Prevention (CDC) “will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance”. The FDA will then review that analysis.

Egter, the FDA said it isrecommending this pauseuntil that review is completed.

In 'n verklaring aan Fox News, Johnson & Johnson said thesafety and well-being of people who use our productsremains the company’s number one priority, and that it was aware of anextremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine.

Fox News’ Brian Flood and Alexandria Hein contributed to this report.

Kommentaar gesluit.